132 related articles for article (PubMed ID: 35861945)
1. Recombinant jurkat cells (HMGN2-T cells) secrete cytokines and inhibit the growth of tumor cells.
Li H; Wu X; Bu D; Wang L; Xu X; Wang Y; Liu Y; Zhu P
J Mol Histol; 2022 Aug; 53(4):741-751. PubMed ID: 35861945
[TBL] [Abstract][Full Text] [Related]
2. HMGN2: An Antitumor Effector Molecule of γδT Cells.
Chen J; Fan Y; Cui B; Li X; Yu Y; Du Y; Chen Q; Feng Y; Zhang P
J Immunother; 2018 Apr; 41(3):118-124. PubMed ID: 29401165
[TBL] [Abstract][Full Text] [Related]
3. HMGN2, a new anti-tumor effector molecule of CD8⁺ T cells.
Su L; Hu A; Luo Y; Zhou W; Zhang P; Feng Y
Mol Cancer; 2014 Jul; 13():178. PubMed ID: 25060707
[TBL] [Abstract][Full Text] [Related]
4. Potential therapeutic strategy for non-Hodgkin lymphoma by anti-CD20scFvFc/CD28/CD3zeta gene tranfected T cells.
Zheng Y; Yu K; Du J; Jiang L; Zhang S; Han Y; Yu P; Tan Y
J Exp Clin Cancer Res; 2010 Sep; 29(1):121. PubMed ID: 20815894
[TBL] [Abstract][Full Text] [Related]
5. Ectopic expression of Hmgn2 antagonizes mouse erythroid differentiation in vitro.
Kulkeaw K; Inoue T; Mizuochi C; Horio Y; Ishihama Y; Sugiyama D
Cell Biol Int; 2012 Feb; 36(2):195-202. PubMed ID: 21988615
[TBL] [Abstract][Full Text] [Related]
6. [Inhibitory effect of recombinant HMGN2 protein on human hepatitis B viral].
He XL; Zhang YH; Jin SH; Feng Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jul; 42(4):461-5. PubMed ID: 21866626
[TBL] [Abstract][Full Text] [Related]
7. Nucleosome-binding protein HMGN2 exhibits antitumor activity in human SaO2 and U2-OS osteosarcoma cell lines.
Liang G; Xu E; Yang C; Zhang C; Sheng X; Zhou X
Oncol Rep; 2015 Mar; 33(3):1300-6. PubMed ID: 25530340
[TBL] [Abstract][Full Text] [Related]
8. [Production of HMGN2 polyclonal antibody by immunization with recombinant GST-HMGN2 fusion protein and its application to analysis of HMGN2 distribution in human monocytes].
Xiong WB; Feng Y; Wang GX; Huang N; Wu Q; Li X; Wang BY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jul; 36(4):451-5. PubMed ID: 16078558
[TBL] [Abstract][Full Text] [Related]
9. Effect of HMGN2 on proliferation and apoptosis of MCF-7 breast cancer cells.
Fan B; Shi S; Shen X; Yang X; Liu N; Wu G; Guo X; Huang N
Oncol Lett; 2019 Jan; 17(1):1160-1166. PubMed ID: 30655878
[TBL] [Abstract][Full Text] [Related]
10. HMGN2 regulates non-tuberculous mycobacteria survival via modulation of M1 macrophage polarization.
Wang X; Chen S; Ren H; Chen J; Li J; Wang Y; Hua Y; Wang X; Huang N
J Cell Mol Med; 2019 Dec; 23(12):7985-7998. PubMed ID: 31596045
[TBL] [Abstract][Full Text] [Related]
11. HMGN2: a novel antimicrobial effector molecule of human mononuclear leukocytes?
Feng Y; Huang N; Wu Q; Wang B
J Leukoc Biol; 2005 Nov; 78(5):1136-41. PubMed ID: 16204630
[TBL] [Abstract][Full Text] [Related]
12. Construction of Anti-CD20 Single-Chain Antibody-CD28-CD137-TCRζ Recombinant Genetic Modified T Cells and its Treatment Effect on B Cell Lymphoma.
Chen F; Fan C; Gu X; Zhang H; Liu Q; Gao X; Lu J; He B; Lai X
Med Sci Monit; 2015 Jul; 21():2110-5. PubMed ID: 26195067
[TBL] [Abstract][Full Text] [Related]
13. [Study on prohibition of high mobility group chromosomal protein N2 against human oral squamous cell carcinoma in vitro].
Dong X; Liu X; Zhang Y; Zhang P; Lu L; Li X; Huang P; Feng Y
Hua Xi Kou Qiang Yi Xue Za Zhi; 2013 Feb; 31(1):91-5. PubMed ID: 23484311
[TBL] [Abstract][Full Text] [Related]
14. Transcriptomic analysis of peripheral blood mononuclear cells in head and neck squamous cell carcinoma patients.
Bin-Alee F; Arayataweegool A; Buranapraditkun S; Mahattanasakul P; Tangjaturonrasme N; Hirankarn N; Mutirangura A; Kitkumthorn N
Oral Dis; 2021 Sep; 27(6):1394-1402. PubMed ID: 32892371
[TBL] [Abstract][Full Text] [Related]
15. [Application of HMGN2-tag constructs to analysis of HMGN2 distribution in HeLa cells].
Xiong W; Feng Y; Huang N; Wu Q; Li X; Wang B
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2005 Oct; 22(5):1015-9. PubMed ID: 16294743
[TBL] [Abstract][Full Text] [Related]
16. Alpha-helical domain is essential for antimicrobial activity of high mobility group nucleosomal binding domain 2 (HMGN2).
Feng Y; Huang N; Wu Q; Bao L; Wang BY
Acta Pharmacol Sin; 2005 Sep; 26(9):1087-92. PubMed ID: 16115376
[TBL] [Abstract][Full Text] [Related]
17. [The Role of HMGN2 in the Development of Periodontitis Dental Plaque].
Luo Y; Li Q; Fan YP; Chen J; Zhang P; Feng Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Jul; 47(4):491-494. PubMed ID: 28591948
[TBL] [Abstract][Full Text] [Related]
18. [High Mobility Group Chromosomal Protein N2 Inhibit Cervical Cancer Transplanted in Nude Mice].
Luo B; Zhang QW; Xu Y; Meng J; Wang XL; Li L; He YD
Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Sep; 47(5):718-721. PubMed ID: 28598086
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of HMGN2 protein on human hepatitis B virus expression and replication in the HepG2.2.15 cell line.
Feng Y; He F; Zhang P; Wu Q; Huang N; Tang H; Kong X; Li Y; Lu J; Chen Q; Wang B
Antiviral Res; 2009 Mar; 81(3):277-82. PubMed ID: 19150374
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial mechanism of high-mobility group nucleosomal-binding domain 2 on the Gram-negative bacteria Escherichia coli.
Li H; Shen XF; Zhou XE; Shi YE; Deng LX; Ma Y; Wang XY; Li JY; Huang N
J Zhejiang Univ Sci B; 2017 May; 18(5):410-420. PubMed ID: 28471113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
